Search research articles
Contact Us
Filters
Showing results (141-150 of 178) with videos related to
Page
of 18
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
April 5, 2019
Identification and Characterization of Functional Human Monoclonal Antibodies to <i>Plasmodium vivax</i> Duffy-Binding Protein
Lenore L Carias, Sebastien Dechavanne, Vanessa C Nicolete, et al.
NPJ Vaccines
|
November 23, 2024
The PvRBP2b-TfR1 interaction is not essential for reticulocytes invasion by Plasmodium vivax isolates from Cambodia
Lionel B Feufack-Donfack, Léa Baldor, Camille Roesch, et al.
Plos Neglected Tropical Diseases
|
May 19, 2023
A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis
Nicholas O Opoku, Felix Doe, Bettina Dubben, et al.
Ebiomedicine
|
June 11, 2024
Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccination
Stefan Gravenstein, Frank DeVone, Oladayo A Oyebanji, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 20, 2019
Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial
Linda Batsa Debrah, Ute Klarmann-Schulz, Jubin Osei-Mensah, et al.
Plos One
|
February 6, 2013
Does malaria affect placental development? Evidence from in vitro models
Alexandra J Umbers, Danielle I Stanisic, Maria Ome, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 17, 2022
Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination
David H Canaday, Oladayo A Oyebanji, Debbie Keresztesy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 16, 2021
Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents
David H Canaday, Lenore Carias, Oladayo A Oyebanji, et al.
The American Journal of Tropical Medicine and Hygiene
|
October 13, 2022
Impact of Environmental Modifications on the Ecology, Epidemiology, and Pathogenesis of Plasmodium falciparum and Plasmodium vivax Malaria in East Africa
Guiyun Yan, Ming-Chieh Lee, Guofa Zhou, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 15, 2021
Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccination
David H Canaday, Oladayo A Oyebanji, Elizabeth White, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 178) with videos related to
Sort By:
Page
of 18
Journal of Immunology (Baltimore, Md. : 1950)
|
April 5, 2019
Identification and Characterization of Functional Human Monoclonal Antibodies to <i>Plasmodium vivax</i> Duffy-Binding Protein
Lenore L Carias, Sebastien Dechavanne, Vanessa C Nicolete, et al.
NPJ Vaccines
|
November 23, 2024
The PvRBP2b-TfR1 interaction is not essential for reticulocytes invasion by Plasmodium vivax isolates from Cambodia
Lionel B Feufack-Donfack, Léa Baldor, Camille Roesch, et al.
Plos Neglected Tropical Diseases
|
May 19, 2023
A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis
Nicholas O Opoku, Felix Doe, Bettina Dubben, et al.
Ebiomedicine
|
June 11, 2024
Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccination
Stefan Gravenstein, Frank DeVone, Oladayo A Oyebanji, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 20, 2019
Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial
Linda Batsa Debrah, Ute Klarmann-Schulz, Jubin Osei-Mensah, et al.
Plos One
|
February 6, 2013
Does malaria affect placental development? Evidence from in vitro models
Alexandra J Umbers, Danielle I Stanisic, Maria Ome, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 17, 2022
Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination
David H Canaday, Oladayo A Oyebanji, Debbie Keresztesy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 16, 2021
Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents
David H Canaday, Lenore Carias, Oladayo A Oyebanji, et al.
The American Journal of Tropical Medicine and Hygiene
|
October 13, 2022
Impact of Environmental Modifications on the Ecology, Epidemiology, and Pathogenesis of Plasmodium falciparum and Plasmodium vivax Malaria in East Africa
Guiyun Yan, Ming-Chieh Lee, Guofa Zhou, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 15, 2021
Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccination
David H Canaday, Oladayo A Oyebanji, Elizabeth White, et al.
Page
of 18